Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Smart Mask Delivers Continuous, Battery-Free Breath Monitoring

By LabMedica International staff writers
Posted on 26 Mar 2026

Exhaled breath offers a noninvasive window into respiratory microenvironments and systemic physiology, but turning it into reliable clinical data remains challenging. More...

Collecting stable exhaled breath condensate (EBC) and operating sensors in high humidity limit continuous monitoring. Passive, wearable capture of biomarkers such as metabolites, pathogens, and inflammatory indicators could expand access across diverse patient groups. Researchers now report a battery-free smart mask platform that extends long-term EBC biochemical sensing with materials and system-level upgrades.

Researchers at the California Institute of Technology (Caltech) have developed an updated platform, EBClite, that cools exhaled breath using a hydrogel to condense and collect exhaled breath condensate (EBC) for analysis. Embedded sensors then quantify target biomarkers and wirelessly transmit the data to a phone, tablet, or computer. To address desiccation that previously limited operation to just a few hours, the system incorporates a lithium chloride–infused hydrogel that resists drying and can be rehydrated, enabling reliable multi-day use.

Sensor robustness in the mask’s high-humidity environment was increased by encapsulating the sensing elements in a flexible multilayer material that tolerates repeated dry–wet cycles. The device now operates solely on an ultrathin integrated solar cell, enabling long-term function without recharging or battery replacement. Materials cost is reported at roughly USD 1 per mask.

The team monitored exhaled lactate in healthy volunteers during different physical activities and after carbohydrate intake; lactate levels in breath increased with activity, similar to blood tests, supporting assessments of energy metabolism. EBC collection is entirely passive, making the approach suitable for user-friendly monitoring across many populations, including children, elderly individuals, and critically ill patients.

Collaborators included Johannes Kepler University (Austria) and The Hong Kong University of Science and Technology. The work was published on March 16, 2026, in Nature Sensors. Early deployment efforts with the Gates Foundation are exploring distribution in parts of Africa, and a simplified version is being developed for tuberculosis monitoring.

“We achieved long-term extension of usability through advances in materials science and system-level engineering design. Building on the original mask, these upgrades enable storage and handling practicality, enhance sensing stability, and achieve energy autonomy,” said Wenzheng Heng, postdoctoral scholar research associate in medical engineering at Caltech.

“We can realize battery-free continuous operation during all different types of indoor activities. The solar cell has high-efficiency energy harvesting even in weak light; you don't have to stand under very strong California sunlight for it to work. The entire mask is now very durable and long lasting,” said Wei Gao, professor of medical engineering at Caltech.

Related Links
Caltech


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

Alzheimer’s disease is the most common cause of dementia, accounting for an estimated 60–70% of cases worldwide. Its progressive effects on memory, thinking, behavior, and daily functioning underscore... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.